Management of an older Marshall-Smith syndrome patient: a review of literature of MSS and craniosynostosis.
Eeshan KhuranaJennifer OrthBeth A PletcherRoger E TurbinCatherine A MazzolaPublished in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2024)
Marshall-Smith Syndrome (MSS) is a rare progressive developmental disorder that severely impairs a patient's intellectual development and physical health. The only known cause for MSS is a mutation in the nuclear factor 1 X (NFIX) gene. This mutation affects neuronal development and protein transcription. Historically, most patients with MSS do not survive beyond 3 years of age. Reports of ocular findings are limited. We report a case of a 9-year-old MSS patient with progressive craniosynostosis, elevated intracranial pressure, and catastrophic ocular complications. A comprehensive PubMed literature search from 2018 to August 2022 updating a previous review of older literature produced 72 articles relating to MSS, which are reviewed.
Keyphrases
- case report
- nuclear factor
- physical activity
- systematic review
- multiple sclerosis
- healthcare
- mental health
- public health
- toll like receptor
- community dwelling
- middle aged
- working memory
- gene expression
- optic nerve
- transcription factor
- emergency department
- risk assessment
- genome wide
- dna methylation
- social media
- protein protein
- binding protein
- electronic health record
- blood brain barrier